COVID-19 UpdatesFree GO2 Foundation for Lung Cancer: COVID-19 patients with pre-existing conditions should receive same treatment as those without April 10, 2020Vol.46 No.15
COVID-19 UpdatesFree Algorithm aims to protect surgical team members against infection with COVID-19 virus April 10, 2020Vol.46 No.15
COVID-19 UpdatesFree Karyopharm to evaluate low-dose Xpovio as potential COVID-19 treatment April 10, 2020Vol.46 No.15
COVID-19 UpdatesFree GSK and Vir Biotechnology collaborate to find COVID-19 solutions April 10, 2020Vol.46 No.15
COVID-19 UpdatesFree OncoSec collaborates with Providence Cancer Institute to conduct phase I study of COVID-19 vaccine April 10, 2020Vol.46 No.15
Conversation with The Cancer LetterCOVID-19 & CancerFree A view from the plateau: As Italy’s cases drop, oncologists plan post-COVID-19 agenda April 10, 2020Vol.46 No.15By Alexandria Carolan
COVID-19 & CancerFree NCI to distribute IL-6 inhibitor for cancer patients with COVID-19 lung inflammation April 10, 2020Vol.46 No.15By Matthew Bin Han Ong
COVID-19 & CancerFreeGuest Editorial Chernobyl doctor’s view of COVID-19: Trump threatens 267 years of progress in biomedical research April 10, 2020Vol.46 No.15By Robert Peter Gale
COVID-19 & CancerFreeGuest Editorial NCTN group chairs: Cancer trials take backseat to clinical care amid COVID-19 pandemic April 10, 2020Vol.46 No.15By Charles D. Blanke, Douglas S. Hawkins, Monica M. Bertagnolli, Peter J. O'Dwyer, Mitchell D. Schnall, Walter J. Curran, Norman Wolmark, Robert S. Mannel and Janet Dancey
